Intranasal delivery of cardiovascular agents: An innovative approach to cardiovascular pharmacotherapy

American Heart Journal

Volumn 127, Issue 6, 1994, Pages 1594-1599

  Landau, Andre J ^a   Eberhardt, Robert T ^a   Frishman, William H ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIOVASCULAR AGENT; CLONIDINE; DIGOXIN; DILTIAZEM; GLYCERYL TRINITRATE; NIFEDIPINE; NITROPRUSSIDE SODIUM; PROPRANOLOL;

ANGINA PECTORIS; BLOOD PRESSURE; DRUG ABSORPTION; DRUG BLOOD LEVEL; HEART DISEASE; HUMAN; HYPERTENSION; INTRANASAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SHORT SURVEY; SUBLINGUAL DRUG ADMINISTRATION;

ABSORPTION; ADMINISTRATION, INTRANASAL; CARDIOVASCULAR AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMAN; NASAL MUCOSA; TIME FACTORS;

EID: 0028243017     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/0002-8703(94)90391-3     Document Type: Article

References (45)

1. Nasal systemic drug delivery
2. Novel drug delivery systems
3. Fine structure of the blood vessels of the human nasal respiratory mucosa
4. Inhibition of the immediate allergic reaction in the nose by beta-2-adrenostimulant fenoterol
5. Effect of a beta-adrenergic agonist, fenoterol, on nasal sensitivity to allergen
6. The effects of topical saline and isoproterenol on nasal airway resistance
7. Nasal blood flow and airway resistance: canine study
8. Adrenoceptors in the Control of Human Nasal Mucosal Blood Flow
9. Decreases in ciliary beat frequency due to intranasal administration of propranolol
10. The transport of crystalline cocaine in the nasal mucous blanket
11. The nasal route of drug administration
12. Nasal absorption of propranolol in rats
13. Nasal absorption of propranolol from different dosage forms by rats and dogs
14. Nasal absorption of propranolol in humans
15. Immediate beta-adrenergic blockade and improved exercise tolerance with intranasal propranolol in patients with angina pectoris
16. Drugs that inhibit the adrenergic nerves and block adrenergic receptors
17. Clinical pharmacology of the new beta-adrenergic blocking drugs. 2. Physiology and metabolic effects
18. Systemic drug interactions with topical glaucoma medications
19. Beta-adrenergic therapy for glaucoma
20. Ophthalmic beta blockers since timolol
21. Bradycardia and congestive heart failure associated with ocular timolol maleate
22. Adverse respiratory and cardiovascular events attributed to timolol ophthalmic solution, 1978–1985
23. Sinus arrest due to timolol eye drops
24. Potential side effects of timolol therapy in the treatment of glaucoma
25. Nifedipine
26. Efficacy of sublingual nifedipine in the acute treatment of systemic hypertension
27. Postoperative hypertension: a comparison of diltiazem, nifedipine and nitroprusside
28. Treatment of hypertensive crisis with intranasal nifedipine [Letter]
29. Nifedipine for control of post-operative hypertension [Abstract]
30. Nifedipine for post-operative blood pressure control following coronary artery vein grafts
31. Intranasal nifedipine for post-bypass hypertension—hemodynamics and pharmacokinetics
32. Efficacy of intranasal nifedipine for relief of intraoperative hypertension
33. Treatment of hypertensive crisis with intranasal nifedipine [Letter]
34. Intranasal administration of nitroglycerin
35. INTRANSAL ADMINSTRATION OF NITROGLYCERINE ATTENUATES THE PRESSOR RESPONSIVE TO LARYNGOSCOPY AND INTUBATION OF THE TRACHEA
36. Intranasal nitroglycerin attenuates pressor response to tracheal intubation in beta-blocker treated hypertensive patients
37. Reflex circulatory responses to direct laryngoscopy and tracheal intubation performed during general anesthesia
38. Myocardial ischemia during noncardiac surgical procedures in patients with coronary artery disease
39. Complications related to the pressor response to endotracheal intubation
40. Studies of anaesthesia in relation to hypertension
41. Variation in the biologic availability of digoxin from four preparations
42. Nasal absorption of digoxin in rats
43. Intravenous clonidine in hypertensive patients
44. Influence of autonomic blockade on the reduction in myocardial performance produced by clonidine
45. Comparison of intravenous and nasal bioavailability of clonidine in rodents